Patents Assigned to Population Council, Inc.
-
Publication number: 20240358633Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.Type: ApplicationFiled: December 8, 2023Publication date: October 31, 2024Applicant: The Population Council, Inc.Inventors: George William CREASY, II, Ruth Beverly MERKATZ, Bruce VARIANO
-
Patent number: 11850251Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: GrantFiled: March 1, 2021Date of Patent: December 26, 2023Assignee: The Population Council, Inc.Inventor: Bruce Variano
-
Patent number: 11793669Abstract: The present invention provides improved intravaginal drug delivery devices, i.e., intravaginal rings, useful for the prophylactic administration of dapivirine in combination with either an antimicrobial compound or a contraceptive to a human. The present invention also provides methods of blocking DNA polymerization by an HIV reverse transcriptase enzyme, methods of preventing HIV infection in a female human, methods of treating HIV infection in a female human, methods of preventing unintended pregnancy in a female human, and methods of preparing intravaginal rings.Type: GrantFiled: January 18, 2022Date of Patent: October 24, 2023Assignee: The Population Council, Inc.Inventors: Brid Devlin, Jonathon Daryll Holt, Andrew Nathan Brimer, Jeremy Peter Nuttall, Karl Malcolm, Susan Margaret Fetherston, Peter John James Boyd
-
Publication number: 20230240982Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: ApplicationFiled: December 2, 2022Publication date: August 3, 2023Applicant: The Population Council, Inc.Inventor: Bruce VARIANO
-
Patent number: 11529308Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: GrantFiled: August 17, 2020Date of Patent: December 20, 2022Assignee: The Population Council, Inc.Inventor: Bruce Variano
-
Patent number: 11331370Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.Type: GrantFiled: November 6, 2018Date of Patent: May 17, 2022Assignees: The Population Council, Inc., The United States of AmericaInventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
-
Publication number: 20220054503Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: ApplicationFiled: November 5, 2021Publication date: February 24, 2022Applicant: The Population Council, Inc.Inventor: Bruce VARIANO
-
Publication number: 20210290637Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: ApplicationFiled: March 1, 2021Publication date: September 23, 2021Applicant: The Population Council, Inc.Inventor: Bruce VARIANO
-
Patent number: 10940157Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: GrantFiled: March 10, 2020Date of Patent: March 9, 2021Assignee: The Population Council, Inc.Inventor: Bruce Variano
-
Patent number: 10925882Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: GrantFiled: March 23, 2020Date of Patent: February 23, 2021Assignee: The Population Council, Inc.Inventor: Bruce Variano
-
Patent number: 10918649Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: GrantFiled: June 21, 2019Date of Patent: February 16, 2021Assignee: The Population Council, Inc.Inventor: Bruce Variano
-
Publication number: 20200397692Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: ApplicationFiled: August 17, 2020Publication date: December 24, 2020Applicant: The Population Council, Inc.Inventor: Bruce VARIANO
-
Publication number: 20200397802Abstract: The present disclosure relates to a vaginal system that prevents pregnancy comprised of segesterone acetate and ethinyl estradiol and is configured for thirteen 28-day product-use cycles.Type: ApplicationFiled: March 23, 2020Publication date: December 24, 2020Applicant: The Population Council, Inc.Inventor: Bruce VARIANO
-
Patent number: 10780047Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.Type: GrantFiled: March 20, 2020Date of Patent: September 22, 2020Assignee: The Population Council, Inc.Inventors: George William Creasy, II, Ruth Beverly Merkatz
-
Patent number: 10765628Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.Type: GrantFiled: March 20, 2020Date of Patent: September 8, 2020Assignee: The Population Council, Inc.Inventors: George William Creasy, II, Ruth Beverly Merkatz
-
Patent number: 10632066Abstract: The present disclosure describes a vaginal system comprising segesterone acetate and ethinyl estradiol configured for thirteen 28-day product-use cycles that is compatible with male condoms comprising natural rubber latex, polyisoprene, or polyurethane and a method of providing birth control using the vaginal system wherein a secondary contraception is employed when the vaginal system is removed or expelled from the vagina for specified amounts of time during any of the product-use cycles.Type: GrantFiled: February 1, 2019Date of Patent: April 28, 2020Assignee: The Population Council, Inc.Inventors: George William Creasy, II, Ruth Beverly Merkatz
-
Publication number: 20190070253Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.Type: ApplicationFiled: November 6, 2018Publication date: March 7, 2019Applicants: The Population Council, Inc., The United States of AmericaInventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
-
Patent number: 10143721Abstract: Disclosed are compositions for inhibiting transmission of a sexually transmitted infection that contain one or more polyanionic microbicides, such as carrageenans, including lambda carrageenan, as well as water-soluble metal salts and specified lectins. Also disclosed are methods for making and using the compositions.Type: GrantFiled: January 13, 2015Date of Patent: December 4, 2018Assignees: The Population Council, Inc., The United States of America, as represented by the Secretary, Dept. of Health and Human ServicesInventors: Barry R. O'Keefe, Melissa Robbiani, José A. Fernández Romero
-
Patent number: 10052335Abstract: Methods for treating neurodegeneration and/or myelination in patients are disclosed comprising treating the patient with a progestin compound which exerts binding to progesterone receptors and elicits progesterone-receptor-induced biological responses without interacting with the androgen receptor and without inducing androgen or glucocorticoid biological responses at a dosage sufficient to prevent or reduce neurodegeneration. The progestin compound preferably comprises 16-methylene-17?-acetoxy-19-norpregn-4-ene-3,20-dione, and the methods include combining the progestin compound with an estrogen compound to provide both contraception and treatment for myelin repair and neurodegeneration.Type: GrantFiled: October 19, 2010Date of Patent: August 21, 2018Assignee: The Population Council, Inc.Inventors: Regine Sitruk-Ware, Michael Maria Helmut Schumacher, Roberta Brinton, Martine El-Etr, Abdelmouman Ghoumari, Rachida Guennoun
-
Patent number: D935018Type: GrantFiled: April 7, 2020Date of Patent: November 2, 2021Assignee: The Population Council, Inc.Inventor: Bruce Variano